Medindia

X

Echo Healthcare Allows DTC Delivery of Shares for Conversion

Monday, November 26, 2007 General News J E 4
Advertisement
VIENNA, Va., Nov. 26 Echo Healthcare AcquisitionCorp. ("Echo" or the "Company") (OTC Bulletin Board: EHHA), a blank checkcompany, today announced that stockholders seeking to exercise conversionrights in connection with Echo's proposed merger with XLNT Veterinary Care,Inc. ("XLNT") will be permitted to transfer their shares for conversionelectronically through Depository Trust Company ("DTC"). Previously, Echo hadindicated that stockholder would be required to deliver physical stockcertificates in order to exercise their conversion rights, thus requiringstockholders holding shares in "street name" to request a physical stockcertificate in time to be delivered for conversion. Now Echo stockholders candeliver shares for conversion electronically for conversion through DTC. Thismeans that stockholders holding shares in "street name" seeking to exerciseconversion rights will not be required to obtain or deliver physical stockcertificates. Only stockholders who vote against the merger proposal areentitled to conversion rights.

Echo has prepared and filed with the SEC a supplement to its proxystatement/prospectus dated November 12, 2007 with additional informationregarding the procedures by which stockholders may exercise their conversionrights. Stockholders who wish to convert their shares should carefully readthe supplement to the proxy statement/prospectus in addition to the proxystatement/prospectus generally. Any stockholder wishing to exercise his/herconversion rights must do so by 12:00 midnight, Denver Time, on December 11,2007. The supplement and the entire proxy statement/prospectus will also beavailable at the Company's website at http://www.echohealthcare.com and athttp://www.sec.gov.

Stockholders considering exercising their conversion rights or withquestions regarding the conversion procedures should contact Thomas P. Skulskiof Morrow & Co. at (203) 658-9400.

About Echo Healthcare Acquisition Corp.

Echo Healthcare Acquisition Corp. is a blank check company that was formedon June 10, 2005 to serve as a vehicle for the acquisition of one or moredomestic or international operating businesses in the healthcare industry. OnMarch 22, 2006, Echo consummated its initial public offering ("IPO") of6,250,000 Units. On March 27, 2006, the Company consummated the closing of937,500 additional Units subject to the underwriters' over-allotment option.The 7,187,500 Units sold in the IPO (including the 937,500 Units subject tothe underwriters' over-allotment option) were sold at an offering price of$8.00 per Unit, which together with the private placement of the 458,333warrants to certain stockholders and directors of the Company at an offeringprice of $1.20 per share, generated total gross proceeds of $58,050,000. Ofthis amount, $54,947,000 was placed in trust. Echo common stock trades on theOTC Bulletin Board under the symbol EHHA.OB. To learn more about Echo, visitthe website at http://www.echohealthcare.com.

About XLNT Veterinary Care, Inc.

XLNT Veterinary Care, Inc. is a provider of veterinary primary care andspecialized services to companion animals through a network of fully-ownedveterinary hospitals. XLNT currently owns and operates 26 veterinary hospitalsin the state of California.

Additional Information about the Merger and Where to Find It

Echo has filed a Registration Statement on Form S-4 with the Securitiesand Exchange Commission ("SEC") in connection with the merger, and has maileda Proxy Statement/Prospectus concerning the proposed merger transaction tostockholders of record as of November 7, 2007. INVESTORS AND SECURITY HOLDERSOF ECHO ARE URGED TO READ BOTH THE PROXY STATEMENT/PROSPECTUS AND RELATINGSUPPLEMENT CAREFULLY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT ECHO,XLNT, THE MERGER AND RELATED MATTERS. Investors and security holders mayobtain the documents free of charge at the SEC's w
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Indevus Pharmaceuticals to Announce Fiscal 2007 Fi...
S
RxElite Announces Ground Breaking of New Corporate...